ORIGINAL RESEARCH article

Front. Immunol.

Sec. Nutritional Immunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1585927

This article is part of the Research TopicNutritional Challenges and Therapies in Youth with Chronic Inflammatory DiseasesView all 5 articles

Relationship between Advanced lung cancer inflammation index and all-cause and cause-specific mortality among Chronic Inflammatory Airway Diseases patients: a population-based study

Provisionally accepted
Zhuanbo  LuoZhuanbo Luo*Peixu  ChenPeixu ChenShiyu  ChenShiyu ChenXue  KongXue KongChao  CaoChao Cao
  • Ningbo First Hospital, Ningbo, China

The final, formatted version of the article will be published soon.

Background: Chronic inflammatory airway diseases pose a significant threat to public health, with its prognosis closely tied to the body's inflammation level and nutritional status. As a composite indicator, the advanced lung cancer inflammation index integrates inflammation and nutritional status. Despite its potential utility, the link between ALI and the prognosis of patients with CIAD remains unexplored.This study aimed to investigate this relationship.We gathered data from the NHANES from 2013 to 2018. Kaplan-Meier analysis was employed to investigate the relationships between ALI and all-cause and cause-specific mortality in patients with CIAD. weighted univariable and multivariable Cox proportional hazards models were employed to further examine their relationship.Multiple factors that could impact the results were adjusted in the analysis. We also utilized a restricted cubic spline analysis to estimate the non-linear relationships between ALI and all-cause and cause-specific mortality rates in patients with CIAD. An elevated ALI was significantly related to a decreased risk of all-cause mortality, as well as mortality from cardiovascular and respiratory diseases among CIAD patients. Results from RCS analysis revealed a reverse J-shaped non-linear association between ALI and all-cause mortality in CIAD patients, with an inflection point at 99.The inflection point in the J-shaped relationship represents the ALI value with the lowest risk of mortality. Conversely, if ALI exceeded 99, a 10-unit increase in ALI resulted in a 3% rise in the risk of all-cause mortality. These findings were consistent across sociodemographic and prior disease-related subgroups, and remained stable in sensitivity analyses.This study revealed a novel association between elevated ALI level and reduced all-cause and cause-specific mortality risk in patients with CIAD.Furthermore, the relationship between ALI and mortality rates from all cause, as well as cardiovascular and respiratory diseases, exhibited an non-linear, J-shaped curve.These findings underscore the importance of maintaining optimal ALI levels within a specific range to promote long-term survival in CIAD patients. The dynamic variation in ALI over time also can help clinicians establish personalized ALI standards to maximize the long-term outcomes for CIAD patients.

Keywords: Advanced lung cancer inflammation index, Chronic inflammatory airway diseases, Mortality, Population-based Study, NHANES

Received: 01 Mar 2025; Accepted: 23 Apr 2025.

Copyright: © 2025 Luo, Chen, Chen, Kong and Cao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Zhuanbo Luo, Ningbo First Hospital, Ningbo, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.